The global Botulism Illness Drugs market size was valued at US$ 156.4 million in 2024 and is projected to reach US$ 203.7 million by 2030, at a CAGR of 4.5% during the forecast period 2024-2030. United States Botulism Illness Drugs market size was valued at US$ 51.2 million in 2024 and is projected to US$ 64.6 million by 2030, at a CAGR of 4.0% during the forecast period 2024-2030.Download FREE ..
